Giancarlo Pruneri

Research interests

Publications

• ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

  Annals of Oncology · 2023 · https://doi.org/10.1016/j.annonc.2023.05.008

• The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

  npj Breast Cancer · 2021 · https://doi.org/10.1038/s41523-021-00346-1

• The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

  The Journal of Pathology · 2020 · https://doi.org/10.1002/path.5406

• ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.03.284

• Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

  npj Breast Cancer · 2020 · https://doi.org/10.1038/s41523-020-0156-0

• Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.01010

• Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30380-2

• Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

  Clinical Cancer Research · 2018 · https://doi.org/10.1158/1078-0432.ccr-18-1390

• ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)

  The Breast · 2017 · https://doi.org/10.1016/j.breast.2017.07.017

• Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourina

  Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161

• Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

  Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000162

• Metabolic shifts in residual breast cancer drive tumor recurrence

  Journal of Clinical Investigation · 2017 · https://doi.org/10.1172/jci89914

• Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

  Seminars in Cancer Biology · 2017 · https://doi.org/10.1016/j.semcancer.2017.10.003

• Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

  Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161

• Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

  Modern Pathology · 2016 · https://doi.org/10.1038/modpathol.2016.109

• Genomic Characterization of Primary Invasive Lobular Breast Cancer

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.64.0334

• The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

  Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu450

• A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

  European Journal of Cancer · 2013 · https://doi.org/10.1016/j.ejca.2013.10.004

• Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.39.3769

• Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.25.5729

• Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer

  Annals of Oncology · 2010 · https://doi.org/10.1093/annonc/mdq072

• The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

  Breast Cancer Research and Treatment · 2008 · https://doi.org/10.1007/s10549-008-0130-2

• Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

  Annals of Oncology · 2007 · https://doi.org/10.1093/annonc/mdm471

• Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

  Blood · 2006 · https://doi.org/10.1182/blood-2005-11-4570

• Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.08.128

• Predicting the Risk for Additional Axillary Metastases in Patients With Breast Carcinoma and Positive Sentinel Lymph Node Biopsy

  Annals of Surgery · 2005 · https://doi.org/10.1097/01.sla.0000150255.30665.52

• Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors

  Clinical Cancer Research · 2004 · https://doi.org/10.1158/1078-0432.ccr-04-0380

• Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution

  Cancer · 2004 · https://doi.org/10.1002/cncr.20809

• Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma

  Cancer · 2001 · https://doi.org/10.1002/1097-0142(20010915)92:6<1378::aid-cncr1460>3.0.co;2-y

• Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

  Blood · 2001 · https://doi.org/10.1182/blood.v97.11.3658

• Angiogenesis in myelodysplastic syndromes

  British Journal of Cancer · 1999 · https://doi.org/10.1038/sj.bjc.6693515

Current projects

No projects listed.